Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2007 August;166(4) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2007 August;166(4):121-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

ORIGINAL ARTICLES   

Gazzetta Medica Italiana Archivio per le Scienze Mediche 2007 August;166(4):121-6

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: Italian

Randomized clinical trial on the use of a new molecule, formulated in suppositories, in the treatment of acute hemorrhoidal disease

Giordano M.

Chirurgo Proctologo, Responsabile Servizio Autonomo di Proctologia Chirurgica, Casa di Cura Villa Igea, Acqui Terme (AL)


PDF


Aim. To value the efficacy of a new molecole, formulated in suppositories, the beclomethasone dipropionate, in the treatment of acute hemorrhoidal disease.
Methods. We have been recruited 240 patients and divided in 3 parallel groups: the first treated with beclomethasone dipropionate, the second with zinc oxide and bismuth and the third with suppositories of hamamelis/hippocastanum/collinsonia.
Results. The pattern of posology has been of a suppository twice day for 45 days. The patients have been valued after 10, 25 and 45 days after the beginning of the treatment, testing clinical signs (bleeding, mucous erythema, thrombosis) and subjective symptoms (itching, pain, tenesmus).
Conclusion. In our study the beclomethasone dipropionate has been quickly efficacious whether on clinical signs or subjective symptoms, with better surprising results on other two tested products. The beclomethasone dipropionate demonstrated excellent tolerability and never collateral effect occurred. Therefore we believe the new molecule, formulated in suppositories, can be very useful for the specialist physician in proctology for the treatment of the acute hemorrhoidal disease.

top of page